Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ophthalmology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    September 2022
  1. BOWMAN SJ, Dorner T, Mariette X, Luo WL, et al
    Ianalumab in Sjogren's syndrome: what can we learn from lupus trials? - Authors' reply.
    Lancet. 2022;400:808-809.
    PubMed    


  2. DYBALL S, Parker B, Bruce IN
    Ianalumab in Sjogren's syndrome: what can we learn from lupus trials?
    Lancet. 2022;400:807-808.
    PubMed    


    August 2022
  3. BAGENAL J, Khanna R, Hawkes S
    Not misogynistic but myopic: the new women's health strategy in England.
    Lancet. 2022 Aug 10. pii: S0140-6736(22)01486.
    PubMed    


    January 2022
  4. WYKOFF CC, Abreu F, Adamis AP, Basu K, et al
    Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00018.
    PubMed     Abstract available


  5. HEIER JS, Khanani AM, Quezada Ruiz C, Basu K, et al
    Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00010.
    PubMed     Abstract available


  6. CHIA MA, Keane PA
    Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease?
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00105.
    PubMed    


  7. SARAUX A, Devauchelle-Pensec V
    Primary Sjogren's syndrome: new beginning for evidence-based trials.
    Lancet. 2022;399:121-122.
    PubMed    


  8. BOWMAN SJ, Fox R, Dorner T, Mariette X, et al
    Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
    Lancet. 2022;399:161-171.
    PubMed     Abstract available


  9. KAMOI K, Uchimaru K, Tojo A, Watanabe T, et al
    HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision.
    Lancet. 2022;399:60.
    PubMed    


    October 2021
  10. AYADI K, Gallaoui S, Ben Nsir A
    Pituitary apoplexy, but not as we thought: a xanthogranuloma rather than an adenoma.
    Lancet. 2021;398:e16.
    PubMed    


    August 2021
  11. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
    PubMed    


    June 2021
  12. TSAGKAS C, Schafer S, Baumgartner A, Muller J, et al
    Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica.
    Lancet. 2021;397:2194.
    PubMed    


    April 2021
  13. BAYAS A, Menacher M, Christ M, Behrens L, et al
    Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00872.
    PubMed    


  14. WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
    Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet. 2021;397:e10.
    PubMed    


    February 2021
  15. NASSIRI N, Maas M, Asanad K, Cacciamani G, et al
    Testicular cancer with neurological symptoms indicates brain metastases.
    Lancet. 2021;397:e7.
    PubMed    


  16. THORNTON J
    Hopes for trachoma control in South Sudan.
    Lancet. 2021;397:461.
    PubMed    


    January 2021
  17. CHAKRABORTY U, Chandra A
    Bitot's spots, dry eyes, and night blindness indicate vitamin A deficiency.
    Lancet. 2021;397:e2.
    PubMed    


  18. GUILLAUME M, Lahary A, Zourdani L, Malandain E, et al
    A painless, sudden loss of vision in sickle cell anaemia: central retinal artery occlusion.
    Lancet. 2021;397:e1.
    PubMed    


    December 2020
  19. SCOTT IU, Campochiaro PA, Newman NJ, Biousse V, et al
    Retinal vascular occlusions.
    Lancet. 2020;396:1927-1940.
    PubMed     Abstract available


    November 2020
  20. LOTERY A, O'Connell A, Harris RA, Sivaprasad S, et al
    Eplerenone for chronic central serous chorioretinopathy - Authors' reply.
    Lancet. 2020;396:1557-1558.
    PubMed    


  21. STANESCU-SEGALL D, Touhami S, Bodaghi B, LeHoang P, et al
    Eplerenone for chronic central serous chorioretinopathy.
    Lancet. 2020;396:1556-1557.
    PubMed    


  22. SACCONI R, Borrelli E, Querques G
    Eplerenone for chronic central serous chorioretinopathy.
    Lancet. 2020;396:1556.
    PubMed    


  23. DIAS L, Araujo R
    Ice pack test in myasthenia gravis: a cool investigation at the bedside.
    Lancet. 2020;396:e82.
    PubMed    


    September 2020
  24. MARINHO PM, Nascimento H, Marcos AAA, Romano AC, et al
    Seeking clarity on retinal findings in patients with COVID-19 - Authors' reply.
    Lancet. 2020;396:e40.
    PubMed    


  25. DUH EJ
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e39.
    PubMed    


  26. COLLISON FT, Carroll J
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e38.
    PubMed    


  27. BRANDAO-DE-RESENDE C, Diniz-Filho A, Vasconcelos-Santos DV
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e37.
    PubMed    


  28. VENKATESH P
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e36.
    PubMed    


  29. OUYANG P, Zhang X, Peng Y, Jiang B, et al
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e35.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: